BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38461059)

  • 1. Bone scintigraphy for cardiac amyloidosis: A Canadian perspective.
    Miller RJ; Akincioglu C
    J Med Imaging Radiat Sci; 2024 Jun; 55(2S):S39-S43. PubMed ID: 38461059
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolated cardiac amyloidosis. Utility of bone seeking tracers scintigraphy in differentiating the subtype of amyloid: A case report.
    Bourogianni O; Papadaki E; Foukarakis E; Koukouraki S
    J Nucl Cardiol; 2019 Feb; 26(1):337-341. PubMed ID: 29476454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tc-99m HDP uptake in cardiac amyloidosis.
    Wadhwa SS; Nour R
    Clin Nucl Med; 1999 Mar; 24(3):156-8. PubMed ID: 10069722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis.
    Singh V; Falk R; Di Carli MF; Kijewski M; Rapezzi C; Dorbala S
    J Nucl Cardiol; 2019 Feb; 26(1):158-173. PubMed ID: 30569412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 99mTc-(V) DMSA uptake in systemic AL amyloidosis and normal bone scintigraphy.
    Sonmez B; Cekic AB; Erkut N; Piskin B; Sonmez M
    Hell J Nucl Med; 2010; 13(1):69-70. PubMed ID: 20411178
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.
    Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP
    Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis.
    Musumeci MB; Cappelli F; Russo D; Tini G; Canepa M; Milandri A; Bonfiglioli R; Di Bella G; My F; Luigetti M; Grandis M; Autore C; Perlini S; Perfetto F; Rapezzi C
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1314-1321. PubMed ID: 31864976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etiology of amyloidosis determines myocardial 99mTc-DPD uptake in amyloidotic cardiomyopathy.
    Longhi S; Bonfiglioli R; Obici L; Gagliardi C; Milandri A; Lorenzini M; Guidalotti PL; Merlini G; Rapezzi C
    Clin Nucl Med; 2015 May; 40(5):446-7. PubMed ID: 25742226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis.
    Treibel TA; Bandula S; Fontana M; White SK; Gilbertson JA; Herrey AS; Gillmore JD; Punwani S; Hawkins PN; Taylor SA; Moon JC
    J Cardiovasc Comput Tomogr; 2015; 9(6):585-92. PubMed ID: 26209459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiac scintigraphy-centered diagnostic process in transthyretin cardiac amyloidosis].
    Ak Sivrikoz I; Çavuşoğlu Y
    Turk Kardiyol Dern Ars; 2020 Jul; 48(5):514-521. PubMed ID: 32633270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Nuclear Imaging Probes for Cardiac Amyloidosis.
    Bravo PE; Dorbala S
    Curr Cardiol Rep; 2017 Jul; 19(7):59. PubMed ID: 28508350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparable image interpretation of 1- and 3-hour technetium-99m HDP scintigraphy for transthyretin cardiac amyloidosis.
    Malhotra S; Singh V; Pilati S; Trepashko D
    J Nucl Cardiol; 2022 Aug; 29(4):2020-2023. PubMed ID: 35676550
    [No Abstract]   [Full Text] [Related]  

  • 13. [Technetium-99m (V) dimercaptosuccinic acid myocardial scintigraphy in a 74-year-old woman with congestive heart failure].
    Hatori T; Iwasaki T; Seki R; Yamagishi T; Toyama T; Kaneko Y; Hasegawa A; Nagai R
    J Cardiol; 1998 Jun; 31(6):381-4. PubMed ID: 9666392
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatic amyloidosis in an i.v. drug abuser detected by bone scintigraphy.
    Ferraro EM; Alfelor FR; Lee M; Poon TT
    Clin Nucl Med; 1987 Apr; 12(4):274-6. PubMed ID: 3581606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal changes in myocardial uptake on serial bone scans in two cases of presumed senile cardiac amyloidosis.
    Davidson RM; Lin DS; Klima M
    Clin Nucl Med; 1993 Oct; 18(10):858-62. PubMed ID: 8242978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myocardial pyrophosphate uptake in cardiac amyloidosis: report of case].
    Redondo F; González P; Ramírez A
    Rev Med Chil; 2002 Mar; 130(3):315-8. PubMed ID: 12043375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial Tc-99m MDP scintigraphy demonstrating increasing cardiac uptake over time in a patient with light-chain cardiac amyloidosis.
    Lin H; Zhang X; Einstein AJ; Tang G
    J Nucl Cardiol; 2022 Aug; 29(4):2024-2028. PubMed ID: 35655112
    [No Abstract]   [Full Text] [Related]  

  • 18. Radionuclide Imaging of Cardiac Amyloidosis and Sarcoidosis: Roles and Characteristics of Various Tracers.
    Hotta M; Minamimoto R; Awaya T; Hiroe M; Okazaki O; Hiroi Y
    Radiographics; 2020; 40(7):2029-2041. PubMed ID: 32976061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In the thick of it: hereditary cardiac amyloidosis identified by
    Smiley D; Einstein AJ; Chan N; Mintz A; Santana DD; Shetty M; Sekulic M; Goldner K; Wall J; Helmke S; Maurer MS
    J Nucl Cardiol; 2023 Jun; 30(3):1258-1262. PubMed ID: 37138173
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bone seeking tracers' scintigraphy for the diagnosis of transthyretin cardiac amyloidosis].
    Daquarti GJ; Meretta A; Corneli M; Costabel JP; Diez M; Masoli OH
    Medicina (B Aires); 2018; 78(6):395-398. PubMed ID: 30504105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.